BPR-6-K-471

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBPR-6-K-471
Drug Alias NameBPR6K471BPR-6-K-471
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora inhibitors
TargetsSerine/threonine-protein kinase Aurora
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNational Health Research Institutes
China Registration ClassN/A

Develop Information

Active CompaniesNational Health Research Institutes
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A